Technology Transfer Office
Transforming Our Discoveries Into Therapeutics
The Technology Transfer Office embodies the spirit of the National Jewish Health brand promise, Science Transforming Life®. We accelerate the development of basic scientific research towards clinical application by identifying and protecting the institution's intellectual property and facilitating business partnerships for technology development, licensing, and commercialization.
National Jewish Health currently has in its portfolio:
- 177 active technologies developed from our research
-
62 active US patents protecting these technologies
- 50 percent of those active US patents are licensed to biotechnology companies for the development of therapeutics consistent with the spirit of the National Jewish Health brand promise, Science Transforming Life®.
Additionally, in the 12 years since the Technology Transfer Office was created, National Jewish Health has:
- executed 205 license agreements, of which 122 are still active;
- executed a total of 1708 material transfer agreements; and
- helped create 8 start-up companies.
Technologies from National Jewish Health
To browse a list of the technologies ready for licensing or further development, select one of the following:
Featured Technology: Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo
Staff
|
Emmanuel Hilaire, PhD
Manager
Phone: 303.398.1262
Susana B. Cestino Read, DVM, MBA
Licensing Associate
Phone: 303.398.1933
Stephanie Piersma
Program Administrator
Phone: 303.398.1045
[email protected] |
Contact Information
National Jewish Health
Technology Transfer Office
1400 Jackson Street, M206
Denver, CO 80206
Fax: 303.270.2352
